Immune cells migrating from the bloodstream to the brain may contribute to seizures in pediatric epilepsy, according to new findings published in the Journal of Experimental Medicine.
A drug originally designed for chemotherapy may reduce allergic responses for a variety of allergens, according to a study published in the Journal of Allergy and Clinical Immunology.
Northwestern Medicine scientists have discovered why Huntington’s disease is so toxic to cancer cells and have harnessed it for a novel approach to treat cancer.
Antibodies that reverse immune system suppression may be able to be used to treat a rare type of melanoma, according to a Northwestern Medicine study published in the journal Nature.
The previously unknown cause of anti-phosphatidylethanolamine (aPE) autoimmunity was discovered in a Northwestern Medicine study published in PNAS.
Northwestern Medicine scientists uncovered the molecular process behind a buildup of toxic proteins in Parkinson’s patients, a discovery that may lead to improved therapies.
Northwestern Medicine scientists have identified a guardian molecule triggered by testosterone that appears to protect males from multiple sclerosis.
Northwestern Medicine scientists have discovered mutations that cause improper drainage and a buildup of ocular pressure leading to glaucoma, suggesting a path towards future treatments.
Northwestern Medicine scientists have demonstrated that tiny vesicles called exosomes released from non-metastatic melanoma cells trigger an immune response that prevents cancer from spreading throughout the body.
Northwestern Medicine scientists have discovered a protein that acts as an entry point for the Epstein-Barr virus, providing a potential target for future therapies.
Notifications